Stephen A. Trowbridge's most recent trade in Angiodynamic Inc was a trade of 890 Common Stock done at an average price of $11.2 . Disclosure was reported to the exchange on Oct. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Purchase of securities on an exchange or from another person at price $ 11.16 per share. | 13 Oct 2025 | 890 | 256,629 (0%) | 0% | 11.2 | 9,932 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.69 per share. | 19 Jul 2025 | 2,585 | 257,123 (0%) | 0% | 8.7 | 22,464 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.69 per share. | 19 Jul 2025 | 717 | 256,406 (0%) | 0% | 8.7 | 6,231 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.99 per share. | 19 Jul 2025 | 667 | 255,739 (0%) | 0% | 9.0 | 5,996 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 86,997 | 86,997 | - | - | Performance Right | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 86,997 | 259,708 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Purchase of securities on an exchange or from another person at price $ 5.86 per share. | 08 Oct 2024 | 1,700 | 172,711 (0%) | 0% | 5.9 | 9,962 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share. | 20 Jul 2024 | 717 | 167,137 (0%) | 0% | 7.1 | 5,112 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.13 per share. | 20 Jul 2024 | 667 | 166,470 (0%) | 0% | 7.1 | 4,756 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 77,905 | 77,905 | - | - | Performance Right | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 76,458 | 76,458 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 38,953 | 167,854 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 14,817 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2024 | 11,142 | 177,612 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.40 per share. | 17 Jul 2024 | 4,016 | 173,596 (0%) | 0% | 7.4 | 29,718 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 17 Jul 2024 | 2,585 | 171,011 (0%) | 0% | 7.2 | 18,560 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 4.67 per share. | 29 Feb 2024 | 1,927 | 128,901 (0%) | 0% | 4.7 | 8,999 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.74 per share. | 20 Jul 2023 | 717 | 115,262 (0%) | 0% | 8.7 | 6,267 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.65 per share. | 20 Jul 2023 | 667 | 114,595 (0%) | 0% | 8.7 | 5,770 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 30,242 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 8,769 | 123,364 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.92 per share. | 19 Jul 2023 | 3,159 | 120,205 (0%) | 0% | 8.9 | 28,178 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.63 per share. | 14 Jul 2023 | 1,362 | 87,664 (0%) | 0% | 9.6 | 13,116 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.56 per share. | 14 Jul 2023 | 376 | 87,288 (0%) | 0% | 9.6 | 3,595 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.43 per share. | 03 Feb 2023 | 555 | 89,026 (0%) | 0% | 13.4 | 7,454 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Purchase of securities on an exchange or from another person at price $ 13.82 per share. | 12 Oct 2022 | 1,083 | 89,581 (0%) | 0% | 13.8 | 14,967 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 18,650 | 18,650 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 15,922 | 15,922 | - | - | Performance Right | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 7,961 | 88,498 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.95 per share. | 15 Jul 2022 | 14,758 | 92,935 (0%) | 0% | 15.9 | 235,390 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 14,758 | 0 | - | - | Non- Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.32 per share. | 15 Jul 2022 | 12,398 | 80,537 (0%) | 0% | 21.3 | 264,325 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 8,357 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 4,188 | 79,686 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.54 per share. | 07 Jul 2022 | 1,509 | 78,177 (0%) | 0% | 20.5 | 30,995 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.48 per share. | 03 Feb 2022 | 583 | 75,498 (0%) | 0% | 20.5 | 11,940 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Purchase of securities on an exchange or from another person at price $ 22.64 per share. | 12 Jan 2022 | 1,000 | 76,081 (0%) | 0% | 22.6 | 22,640 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2021 | 10,946 | 79,254 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2021 | 9,437 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.29 per share. | 12 Aug 2021 | 4,173 | 75,081 (0%) | 0% | 27.3 | 113,881 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.10 per share. | 26 Jul 2021 | 353 | 68,308 (0%) | 0% | 26.1 | 9,213 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 20,128 | 20,128 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2021 | 13,625 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.07 per share. | 15 Apr 2021 | 13,625 | 73,371 (0%) | 0% | 14.1 | 191,704 | Common Stock |
| Angiodynamic Inc | Stephen A. Trowbridge | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.21 per share. | 15 Apr 2021 | 10,080 | 63,291 (0%) | 0% | 24.2 | 244,037 | Common Stock |